Purpose: The hematopoietically active (or red) bone marrow is the target tissue assigned in skeletal dosimetry models for assessment of stochastic effects (leukemia induction) as well as tissue reactions (marrow toxicity). Active marrow, however, is in reality a surrogate tissue region for specific cell populations, namely the hematopoietic stem and progenitor cells. Present models of active marrow dosimetry implicitly assume that these cells are uniformly localized throughout the marrow spaces of trabecular spongiosa. Data from Watchman et al. and Bourke et al., however, clearly indicate that there is a substantial spatial concentration gradient of these cells with the highest concentrations localized near the bone trabeculae surfaces. The purpose of the present study was thus to explore the dosimetric implications of these spatial gradients on active marrow dosimetry. Methods: Images of several bone sites from a 45-yr female were retagged to group active marrow voxels into 50 lm increments of marrow depth, after which electron and alpha-particle depth-dependent specific absorbed fractions were computed for four source tissues -active marrow, inactive marrow, bone trabeculae volumes, and bone trabeculae surfaces. Corresponding depth-dependent S values (dose to a target tissue per decay in a source tissue) were computed and further weighted by the relative target cell concentration. These depth-weighted radionuclide S values were systematically compared to the more traditional volume-averaged radionuclide S values of the MIRD schema for both individual bones of the skeleton and their skeletal-averaged quantities. Results: For both beta-emitters and alpha-emitters localized in the active and inactive marrow, depth-weighted S values were shown to differ from volume-averaged S values by only a few percent, as dose gradients across the marrow tissues are nonexistent. For bone volume and bone surface sources of alpha-emitters and lower energy beta-emitters, when marrow dose gradients are expected, explicit consideration of target cell spatial concentration gradients are shown to significantly impact marrow dosimetry. Conclusions: For medical isotopes currently utilized for treatment of skeletal metastases, namely 153 Sm and 223 Ra, accounting for hematopoietic stem and progenitor cell concentration gradients resulted in maximum percent differences to reference skeletal-averaged S values of~21% and 55%, respectively.
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INTRODUCTION
Irradiation of the skeletal tissues, either by internalized radionuclides or by external radiation fields, has the potential to induce two forms of stochastic radiation effectleukemia and bone cancer. 1 At higher radiation levels, tissue reactions may arise ranging from a temporary reduction to permanent loss of hematopoietic activity (marrow toxicity). 2 Current methods of skeletal dosimetry have defined the hematopoietically active bone marrow as the target tissue for risks of both leukemia and marrow toxicity, while the bone endosteum is the associated target tissue for bone cancer risk. Active marrow and bone endosteum are in reality surrogate tissue regions for specific radiosensitive cell populations for which dose estimates are sought in predictive models of dose response. Active marrow thus serves as the surrogate tissue for the hematopoietic stem and progenitor cells (HSPCs), whereas bone endosteum serves as the surrogate tissue region for the osteoprogenitor cells (OPCs). 3 Current radiological protection models assume that the OPCs are localized within a marrow depth of 50 lm from the surfaces of bone trabeculae. 4 These same models of skeletal dosimetry -constructed from either bone/marrow pathlength distributions or 3D microimaging -further assume that the HSPCs are concentrated uniformly across the marrow spaces of trabecular spongiosa. 5, 6 Studies by Watchman et al. 7 and Bourke et al., 8 however, clearly show that there exists a significant depthdependent concentration gradient of the HSPCs. The purpose of the present study was thus to explore the dosimetric implications of these spatial gradients on active marrow dosimetry. 9 The radionuclides selected in this study include both beta-particle and alpha-particle emitters.
DATA SOURCE FROM PREVIOUS STUDIES

2.A. MicroCT-based models of skeletal spongiosa
Presently, two general classes of computational models exist for the assessment of radiation dose to active bone marrow: 1D pathlength-based models and 3D image-based models. The foundation of pathlength-based models originated from the studies of Frederick Spiers and the Bone Dosimetry Research Unit at the University of Leeds in the 1960s to early 1980s. [10] [11] [12] [13] Their work completed studies of a 44-yr-old adult male cadaver in which seven bone sites were imaged using contact radiographs. The acquired linear pathlength distributions across the marrow spaces and bone trabeculae from this individual formed the basis for the majority of skeletal dosimetry models that followed, including those in MIRD Pamphlet No. 11, 14 ICRP Publication 30, 15 and that of Stabin and Siegel. 16 In contrast, image-based models of skeletal dosimetry rely fully on 3D images of individual bones at both their macroscopic and microscopic dimensions. The former includes geometric modeling of trabecular spongiosa and its surrounding cortex of cortical bone based upon clinical CT imaging, while the latter further defines the tissues of spongiosa -bone trabeculae and marrow cavities -through either NMR microscopy or microCT imaging. Primary examples of image-based models include those of the Kramer laboratory in Brazil [17] [18] [19] and the Bolch laboratory in the US. 6, 20, 21 In 2016, O'Reilly 22 created a comprehensive electron skeletal model of the reference adult female as defined in ICRP Publications 70 1 and 89. 23 This model followed that by Hough et al. for the reference adult male. 6 The O'Reilly model was based on studies of 37 excised bone sites from a 45-yr-old female cadaver. Cored samples of trabecular spongiosa were imaged via microCT at 30 lm resolution. These bone microstructural images, coupled with ex-vivo CT images of the bone macrostructure, were used for radiation transport of monoenergetic electrons in various source tissues to include active and inactive bone marrow (AM and IM), trabecular bone volumes and surfaces (TBV and TBS), and cortical bone volumes and surfaces (CBV and CBS). Target tissues included both the active marrow and bone endosteum, defined as the surrogate tissue regions for marrow stem cells and osteoprogenitor cells, respectively. Bone macrostructural models were taken directly from the individual bones within the University of Florida (UF) hybrid computational phantom of the reference adult female. 24, 25 The bone images of the O'Reilly model are used in the present study to reassess electron and alpha particle dosimetry to active bone marrow as a function of depth within the marrow cavities. Figure 1 shows images of the L1 vertebrae -both its bone macrostructure and bone microstructure -from this reference adult female skeletal model.
2.B. Depth-dependent distribution of HSPCs
In studies by Watchman et al., 7 and later by Bourke et al., 8 the spatial distributions of CD34 + HSPCs within the marrow cavity of human trabecular bone were assessed. *, 26 Watchman et al. examined core-biopsy specimens from the iliac crest of 12 individuals. These samples were immunohistochemically stained for CD34 + expression, after which their displacement from the nearest bone trabecula surface was measured and binned in depth increments of 50 lm. These data were used to report the number of stem and progenitor cells per unit area of total marrow space. Linear spatial gradients were observed out to a maximum marrow depth of 700 lm.
Bourke et al. extended this study using cadaveric widearray tissue images of not only the iliac crest, but also the ribs and L1 vertebrae from eight individuals. Marrow adipocytes were explicitly segmented, and thus areal cell concentrations in this later study were given relative to the hematopoietically active, not total, area of the marrow spaces.
† These authors also observed a roughly linear decline in areal CD34 + HSPC concentrations with marrow depth which were fairly independent of bone site. Bourke et al. determined that 50% of the hematopoietic stem cell populations were located within only the first 100 lm of the trabeculae surfaces. The data presented in Bourke et al. were used in the present study to develop depth-dependent concentration weighting factors for radionuclide S values, following a schema originally proposed in the Watchman et al. study.
MATERIALS AND METHODS
3.A. Depth-dependent modeling of the skeletal microstructure
In the present study, 20 bone sites were modeled within the skeleton of the reference adult female. These included 11 * The CD34 protein is a member of a family of single-pass transmembrane proteins that show expression on early hematopoietic and vascular-associated tissues. In the studies by Watchman et al. and Bourke et al., differentiation of hematopoietic (CD34+/CD31-) and vascular tissues (CD34+/CD31+) was made through simultaneous immunohistochemical staining for both CD34 and CD31 antigens in the marrow tissues. † Active marrow in the study by Bourke et al. was thus defined as all regions of the tissue histology images not already occupied by either bone trabeculae or segmented marrow adipocytes.
within the axial skeleton (craniofacial bones, mandible, scapulae, clavicles, sternum, ribs, cervical vertebrae, thoracic vertebrae, lumbar vertebrae, sacrum, and os coxae), four within the arms (humerus, radius, ulnae, and wrist/hands), and five within the legs (femur, patella, tibia, fibula, and ankles/feet). Long bones were separated into their proximal and distal regions. The macrostructural geometry of each bone site was taken directly from the skeleton of the reference adult female model (UFHADF) of the UF hybrid phantom series. 24, 25 Table II gives values of homogeneous bone volume within the computational phantom, along with their corresponding volume fractions of cortical bone, trabecular spongiosa, and in the case of the long bones, the medullary cavities of the shafts. For the vertebral columns, all constituent vertebrae were considered so that particle crossfire between individual vertebrae could be considered (relevant only to electron sources). The voxel resolutions differed for each bone site, so as to optimize to a targeted image matrix size of 54 million voxels. 27 The corresponding microstructures for these bone sites were taken from some 37 microCT images of cored spongiosa reported by O'Reilly. 28 For many of the bone sites, only a single representative sample was taken (e.g., iliac crest to represent the os coxae). For other sites, multiple microCT images were acquired (e.g., frontal bone, right parietal bone, and occipital bone to represent the craniofacial bones). Table II further shows site-averaged volume fractions for trabecular bone, total marrow, and bone endosteum for each major skeletal site. The final column of Table II gives the ICRP-defined marrow cellularity for each bone site. MicroCT images of the distal radius and distal fibula were used as surrogates for the microstructure of the wrists/hands and ankles/ feet, respectively. While the original images were acquired at 30 lm resolution, these images were resampled to yield geometric models of cubic voxels of 50 lm on edge (see O'Reilly et al. 22 ). This step allowed the first voxel layer to thus represent the bone endosteum. It further facilitated matching of depth-dose data with the HSPC spatial gradients reported in Bourke et al.
To investigate depth-dependent energy deposition, voxels within the marrow cavities of each segmented microCT image were tagged in three dimensions as a function of distance away from the nearest bone trabecula surface in 50 lm increments. At each depth, existing active marrow voxels and inactive marrow voxels were each indexed as a function of depth from the nearest bone trabecula. The radiation transport code MCNPX v.2.7 was used in the present study. 29 MCNP is a well-established radiation transport tool for both medical and occupational radiation dosimetry applications, and is supported by the Los Alamos National Laboratory (https://mcnp.lanl.gov/). Details of its application in the present study are given in Table I . For monoenergetic electron simulations, 25 source energies were considered ranging from 10 keV to 10 MeV along a standard grid defined by the ICRP. 30 Monoenergetic alpha particles were simulated at 15 energies, ranging from 3 MeV to 10 MeV in 0.5 MeV increments. All bone sites were modeled at ICRP-defined marrow cellularities.
1 Elemental composition and mass densities for all bone sites were taken from FIG. 1. Macrostructural model (left -6.4 cm 9 11.2 cm 9 5.8 cm), microCT image of cored spongiosa (middle -2.1 cm 9 1.7 cm), and resulting segmented microstructural model (right -2.1 cm 9 1.7 cm 9 1.8 cm) of the adult female L1 vertebra. The macrostructural model defined regions of cortical bone and spongiosa. While spongiosa is a homogeneous region in the macrostructural model, it is explicitly defined as regions of trabecular bone (light gray) and marrow tissues (black) in the corresponding microstructural model of the bone site.
the study by O'Reilly 28 as based upon reference values given in ICRU Report No. 46. 31 For simulations of the bone macrostructure (bones from the UFHADF phantom), the source and target region was the trabecular spongiosa. These simulations thus quantified the fraction of electron energy deposited outside trabecular spongiosa (e.g., cortical bone and surrounding tissues). Relative errors were below 1% for all bone macrostructure simulations. Localized monoenergetic photon contributions to marrow dose were assessed using energy-dependent fluence tallies in the spongiosa of the bone macrostructural models and fluence-to-dose response functions as reported by Johnson et al. 32 (Table II) . For bone microstructure simulations (spongiosa microCT images), the target region was active marrow. Source regions included active marrow, inactive marrow, trabecular bone surfaces, and trabecular bone volumes. Relative errors were kept below 1% for voxels within range of the starting particle, but relative errors were allowed to deviate further for distant voxels where statistical errors were unavoidable due to the marrow cavity size, the particle range, and the limited numbers of voxels at deeper marrow depths. Final values of absorbed fraction were computed as the product of those from the bone macrostructure transport (infinite spongiosa) and bone microstructure transport (electron escape fraction) as outlined in Wayson et al. 33 and O'Reilly et al. 22 
3.C. Absorbed fractions, specific absorbed fractions, and radionuclide S values
In this study, the absorbed fraction (AF) and specific absorbed fraction (SAF) to active marrow were computed as:
where /(AM r S , E i ) is the AF to active marrow (AM) at particle energy E i from a given source region r S , E deposited is the energy deposited in active marrow, Φ(AM r S , E i ) is the SAF to active marrow from a particular source region, and m AM is the mass of active marrow. These equations relate to a simulation where one is averaging energy deposition across the entire marrow cavity (volume-averaged AF). If one were to compute depth-dependent SAFs, the following expression is used:
where the AF and target mass are now indexed to a particular marrow depth d. The volume-averaged SAF is thus computed as the ratio of the summation of depth-dependent AFs and depth-dependent active marrow masses:
For bone sites whose microstructure is taken from a single microCT image of cored spongiosa (e.g., the mandible and scapula), the AF is simply the computed AF for that single bone site. However, for bone sites whose microstructure is taken from multiple microCT images of cored spongiosa (e.g., cranium and lumbar vertebrae), the AF must be averaged over all constituent bone microstructures. Average values of AF were thus computed as using marrow volume fractions (MVF), trabecular bone surface areas (TBSA), and trabecular bone volume fractions (TBVF) as relative weights for each bone constituent as established in Pafundi et al. 20 In the present study, this averaging process was further extended to depth-dependent AFs to active marrow targets:
where MVF d,j is the marrow volume fraction of the constituent bone site j at a particular depth d. Depth-dependent SAFs further required estimates of the depth-dependent active marrow masses m AM,d as given by:
where V mac is the volume of the homogeneous bone macrostructure, SVF mac is the spongiosa volume fraction of the bone macrostructure, MVF mic is the marrow volume fraction of the bone microstructure, and q AM is the density of active marrow (1.03 g cm À3 ). The last term in Eq. (8) is an estimate of the depth-dependent marrow cellularity. This value is very nearly equal to the assigned reference marrow cellularity for the entire bone microstructure, as marrow voxels in the original binary image are randomly assigned as either active or inactive bone marrow as per the findings by Shah et al. 34 which demonstrated little to no spatial gradient in marrow cellularity with depth into the marrow cavities.
To compute the mean absorbed dose to active marrow over a given dose-integration period s, the MIRD schema may be used as defined below:
DðAM; sÞ ¼Ãðr S ; sÞ SðAM r S Þ
whereÃðr S ; sÞ is the time-integrated activity (i.e., total number of decays) in the source tissue r S over time s, and SðAM r S Þ is the radionuclide S value -the absorbed dose to active marrow per nuclear transformation in that source 
Source description
Source regions included bone marrow (active and inactive), trabecular bone (surfaces and volumes), and cortical bone (volumes) as defined in both the macrostructural (CT-based) and microstructural (microCT-based) models of the skeleton sites. Monoenergetic electrons were considered at 25 energies from 10 keV to 10 MeV. Monoenergetic alpha particles were considered at 15 energies from 3 MeV to 10 MeV.
Ref. 22
Crosssection libraries ENDF/B-VII Ref. 29 
Transport parameters
Electrons and alpha particles were transported to a cutoff energy of 1 keV, after which their kinetic energy was assumed to be locally deposited.
Ref. 29
Variance reduction
No variance reduction was applied in this study
Scored quantities *F8 Tally -Energy deposition in the cell of interest (MeV). This tally was utilized for assessment of electron and alpha particle specific absorbed fractions (SAFs). F4 Tally -Volumetric fluence in the cell of interest (units of cm À2 ). This tally was utilized for assessment of photon SAFs.
Refs. 29 and 32
Number of histories and statistical uncertainty
Particle histories were varied so as to reduce relative errors in the *F8 and F4 tallies reported by MCNPX. For simulations of the bone macrostructure (whole bones from adult female hybrid phantom), relative errors in energy deposition scoring were below 1%. For simulations of the bone microstructure (spongiosa microCT images), relative errors were kept below 1% for voxels within range of the starting particle, but were allowed to deviate further in more distant voxels where statistical errors were unavoidable due to the marrow cavity size, the particle range, and the limited numbers of voxels at deeper marrow depths.
Ref.29
Data postprocessing
Energy deposition recorded in regions of interest (*F8 tallies) was divided by initial kinetic energy of particle giving the absorbed fraction (AF). The AF was further divided by the mass of the target region to give the specific absorbed fraction (SAF) for the specified bone site. SAFs for each marrow depth were maintained separately and summed to yield volumeaveraged SAFs. Reference decay data on particle energies and yields from ICRP Publication 107 were utilized to computed radionuclide S values using both the depth-dependent and the volume-averaged SAFs. Depth-dependent S values were then weighted by depth-dependent CD34+ HSPC concentration weighting factors and summed to create depth-dependent S values for comparison to volume-averaged S values.
Refs. 9,35 and 36
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tissue. 9 Depth-dependent S values S(AM r S , d) and volume-averaged S values S(AM r S ) are computed as:
where E i is the energy of the i th nuclear transition and Y i is the number of nuclear transitions per nuclear transformation for the radionuclide of interest. S values reported in this study were computed via an in-house MATLAB TM script using values of particle energies and yields taken from ICRP Publication 107, 35 which include the full spectrum of beta-particle energies. Dose contributions by alpha-particle recoil nuclei were evaluated using extrapolated SAFs for 2-MeV alpha particles -an approach identical to that made by the ICRP in their Publication 133. 36 S values are reported here in the units of mGy per MBq-s. 
3.D. HSPC concentration derived depth-dependent S value weighting factors
As originally outlined in Watchman et al., 7 depth-dependent weighting factors may be derived to compute corresponding depth-dependent radionuclide S values for bone-seeking radionuclides. In this study, these weighting factors are based on study data from Bourke et al. 8 which included depth-dependent CD34 + areal concentrations from the iliac crest, ribs, and L 1 vertebrae taken from eight patients at autopsy. For each patient, the number of pixels of active bone marrow were counted in binned depths of 50 lm from the nearest bone trabecula surface. This pixel count was scaled by a conversion factor of 2.788 9 10 À6 mm 2 /pixel 2 taken from an original calibration measurement of 0.6 pixels/ lm within the images. This conversion resulted in the active marrow area (in mm 2 ) for a given 50 lm depth out to a maximum depth of 700 lm. No CD34 + cells were found at depths exceeding this value in any patient bone sample.
The total active marrow area was then summed over all depths (0-700 lm) for all study patients. Patient percent contributions were calculated based upon total active marrow area imaged for each patient. Next, CD34 + cells were then counted for each 50 lm depth for all eight patients. The total active marrow area at each depth was then divided by the total active marrow area summed over all depths to give the relative active marrow area at each depth. This process was repeated for all bone sites and for all patients. The relative active marrow areas at each depth for each patient were multiplied by the patient-specific percent contribution and these products were summed over all patients, resulting in a weighted average active marrow area XðdÞ (in mm 2 ) for each depth d.
Next, the total number of CD34 + cells at a depth bin d was divided by the total active marrow area in that same depth. This concentration value was defined as qðdÞ with units of cells/mm 2 . For all patients at each depth bin, qðdÞ was multiplied by the patient-specific percent contribution and this product was summed over all patients, resulting in an average areal density (cells/mm 2 ) for all patients, defined as qðdÞ, for each depth. The parameter qðdÞ was then normalized for all depths by dividing the qðdÞ at depth by the sum of qðdÞ over all depths. These values were then plotted and fit to a linear function for each skeletal site (see Figs crest, rib, and L1, respectively). Using the equation of each fitted line, qðdÞ values were defined in 50 lm depth increments, beginning at 25 lm (corresponding to midpoints at each 50 lm depth bin). S value weighting factors x HCD34 d at these depths were thus determined as follows: were next linearly averaged for the three bone sites, at each depth, resulting in single set of depth-dependent weighting factors for radionuclide S values. Weighting factors for the three skeletal sites as well as the final averaged values are shown in Table III .
These weighting factors were renormalized to unity for bone sites whose marrow cavities did not extend to 700 lm. Depth-weighted radionuclide S values to active marrow in a particular skeletal site S DW ðAM r S Þ are thus given as:
SðAM r S ; dÞ is the depth-dependent S value to active marrow from a source tissue r S , and x
HCD34 d
is the depth-dependent CD34 + HSPC concentration weighting factor. When necessary, the depth bins were truncated to a maximum 700 lm as observed by both Watchman et al. 7 and Bourke et al. 8 The difference between the depth-weighted radionuclide S value S DW ðAM r S Þ and the volume-averaged radionuclide S value SðAM r S Þ is that the former accounts for the spatial gradient of the target cells, while the latter implicitly assumes these cells are uniformly distributed within the marrow cavities. In terms of dose assessment, the former allows for the assessment of the mean absorbed dose to the CD34+ hematopoietic stems, while the latter allows for the assessment of the mean absorbed dose to its surrogate tissue region -active bone marrow -as shown in Eqs. (14) and (15) 
3.E. Skeletal-averaged radionuclide S values
The methods previously described allow us to investigate the impact on the CD34 + HSPC concentration spatial gradients on radionuclide S values within individual bones of the skeleton of reference adult female. Nevertheless, active marrow dose is not typically reported on a bone-by-bone basis, but instead as a skeletal-averaged quantity. Following the formulations given in Appendix B from Pafundi et al., 20 skeletal-averaged radionuclide S values -both volume-averaged and depth-weighted -are computed as:
where S x (AM r S ) and S DW,x (AM r S ) are the volumeaveraged and depth-weighted radionuclide S values, respectively, to active marrow from source region r S within bone site x, f x,AM is the fraction of total skeletal active marrow mass located in bone site x, and f x,s is the fractional mass or surface area of the skeletal source tissue located in bone site x. Values of both f x,AM and f x,s are reported in the study by O'Reilly 28 for the UF reference adult female.
RESULTS
In the following sections, electron and alpha-particle sources tissues include the active marrow, inactive marrow, trabecular bone volumes, and trabecular bone surfaces. These regions are abbreviated as AM, IM, TBV, and TBS, respectively, in all subsequent figures and tables. Specific absorbed fractions -both volume-averaged and depth-dependentare shown here for the os coxae only. A full set of SAFs for all bone sites is given in Annex A and B for transported electrons and alpha particles, respectively (see Annex S1 and S2 in Supporting Information).
4.A. Depth-dependent electron SAFs
As a quality assurance measure, depth-dependent values of electron AF and active marrow mass in the adult female os coxae were used to compute volume-averaged SAFs for AM, IM, TBV, and TBS sources using Eq. (4) . These values are shown in Fig. 4 , along with corresponding values from O'Reilly 28 where volume-averaged SAFs were computed directly during electron transport. Percent differences for all sources were under 3% with median values below 1%, showing good agreement between both studies. For AM sources, the SAF to the active marrow target declines initially with increasing electron energy due to energy loss to both marrow adipocytes and to the bone trabeculae. At energies above 1 MeV, a further decline is observed as electron energy is further lost to the surrounding cortex of cortical bone. For TBS sources, the SAF is initially energy-independent over the energy decade 10 to 100 keV, after which it rises as electrons reach sufficient energy to penetrate the local bone trabecula and irradiate regions of active marrow on its far side. This is contrast to TBV sources in the same energy range where increasing particle energy is first required for electrons to fully emerge from the source bone trabecula. At energies above~1 MeV, the SAF to active marrow increasingly becomes source independent.
Energy-and depth-dependent SAFs are shown in Figs. 5(a) and 5(b) for active marrow and inactive marrow electron sources, respectively. As particle emissions for these source tissues are generally uniformly dispersed across the marrow cavities, spatial gradients in radiation absorbed dose are nonexistent, resulting in little to no change in active marrow SAFs with increasing marrow depth. The one exception for both source regions are lower energy electrons (< 500 keV) within the 0-50 lm depth bin, where SAF values are slightly lower than at deeper marrow depths. This is directly attributed to the loss of an isotropic irradiation geometry in the marrow voxels immediately adjacent to the bone trabecula.
Corresponding values of energy-dependent and depthdependent SAF values for electron sources localized in the volumes (TBV) and on the surfaces (TBS) of the bone trabeculae are shown in Figs. 6(a) and 6(b), respectively. For these source geometries, one expects to see a significant spatial dose gradient across the marrow cavities, one that is enhanced at lower particle energies. The data shown exactly reflect this expectation, with SAF profiles that increasingly shift to higher energies at deeper marrow depths. For both TBV and TBS electron sources, the SAF energy profiles for the first 50-lm marrow depth bin in fact are higher than the volume-averaged SAF across all electron energies. The electron energy for TBS and TBV sources must exceed 80 keV and 90 keV, respectively, before the SAF at the depth bin of 50-100 lm exceeds the volume-averaged SAF. For both TBV and TBS sources, electron SAFs begin to become depth-independent at energies above 1 MeV, indicating that there no longer exists a significant dose gradient across the marrow cavities. These very different patterns of energy deposition across the marrow cavities -AM and IM sources versus TBV and TBS sources -have direct implications on differences between volume-averaged and depth-weighted radionuclide S values, as will be discussed later.
4.B. Depth-dependent alpha particle SAFs
Very similar studies of depth-dependent SAFs to active bone marrow were performed for transported alpha particles. Figure 7 displays values of the energy-dependent volumeaveraged SAFs to AM for alpha particles in the energy range of 3 to 10 MeV. For AM and TBS alpha-particle sources, the SAF to active marrow steadily declines with increasing particle energy due mostly to increasing energy loss to marrow adipocytes and to the bone trabeculae. For IM and TBV alpha-particle sources, the corresponding SAF increases with increasing particle energy, reflecting the increasing ability to escape these source regions and irradiate surrounding regions of active marrow.
Corresponding energy-dependent but also depth-dependent alpha-particle SAFs to active marrow are given in Figs. 8(a) and 8(b) (AM and IM sources, respectively) and in Figs. 9(a) and 9(b) (TBV and TBS sources, respectively). In a pattern very similar to that seen for electrons, the data of Figs. 8(a) and 8(b) show very little depth dependence in SAFs to active marrow for alpha particles, with the exception once again of the first depth bin at 0-50 lm (local shielding by the adjacent bone trabecula). For TBV sources of alpha particles ( Fig. 9(a) ), the SAF to active marrow varies over 5 orders of magnitude between the 0-50 lm and the 150-200 lm depth bins, while for TBS sources of alpha particles (Fig. 9(b) ), the SAF to active marrow correspondingly vary over~4 orders of magnitude. For the very first 50-lm depth bin, the SAF to active marrow is shown to be approximately a factor of 10 higher than the volume-averaged SAF for both TBV and TBS sources. In Fig. 9(a) , the alpha-particle SAF to active marrow for the 50-100 lm depth bin only approaches its volume-averaged SAF at an alpha-particle energy of 10 MeV for TBV sources. For the TBS sources shown in Fig. 9(b) , an energy of 8.5 MeV is required for the SAF to active marrow for the 50-100 lm depth bin to equal its volume-averaged SAF. It is noted that for alpha-particle sources localized to the TBV or TBS, energy deposition scoring at marrow depths beyond 200 lm was very small and subject to high relative error. Consequently, in the present study, alpha-particle SAFs for bone trabeculae sources were set to zero at depths exceeding 200 lm.
DISCUSSION
The availability of depth-dependent SAFs to active bone marrow for both electron and alpha particles emitted within a variety of skeletal sources tissues permits one to explore the dosimetric impact of stem and progenitor cell concentration gradients over the same scale of marrow depths. The parameters to be compared are the traditional volume-averaged radionuclide S value SðAM r S Þ from Eq. (11) (which implies a depth-independent concentration of target cells) and the depth-weighted radionuclide S value S DW (AM from Eq. (13) (which explicitly weights marrow dose with depth in proportion to the target cell concentration). For discussion purposes, we present in Table IV values of SðAM r S Þ and S DW ðAM r S Þ, as well as their percent difference, in the ribs, lumbar vertebrae, and os coxae for the beta-particle emitters 45 Ca, 153 Sm, and 90 Y. Comparable data are given in Table V for the alpha-particle emitters  223 Ra,  211 At, and 212 Bi. A more extensive set of radionuclides S values -both volume-averaged and depth-weighted -are given in Annex C for all bone sites of the reference adult female, and for additional beta-emitting and alpha-emitting radionuclides (see Annex S3 in Supporting Information).
In both Table IV (electron emitters) and Table V (alphaparticle emitters), differences between volume-averaged and depth-weighted S values for active marrow and inactive marrow sources are shown to be very small (À4% to +2%). This finding is consistent with the data of Figs. 5 and 8 which demonstrated minimal changes in AM dose with marrow depth. Consequently, all regions of the marrow cavities receive a nearly uniform radiation dose, and thus any spatial variation in target cell concentration is irrelevant to estimates of cellular-level radiation dose. It is acknowledged that this study focuses on radiation dose as a deterministic quantity under the MIRD schema, 9 and thus no consideration is given to cellular-level probability distributions of dose as would be considered in a microdosimetric analysis. 37 The situation is very different, however, for electron and alpha-particle emitters associated with the bone trabeculae, where the data of Figs. 6 and 9 clearly indicate a substantial dose gradient for electrons below 1 MeV, and for all alphaparticle energies considered (3 to 10 MeV). For the lowest beta-emitter 45 Ca, depth-weighted S values are 75%, 31%, and 142% higher than volume-averaged S values in the ribs, lumbar vertebrae, and os coxae, respectively. These differences decline to values of 4%, 1%, and 10% for the higher energy beta-emitter 90 Y as is predicted by the convergence of depth-dependent SAFs shown in Fig. 6 . For alpha-emitters within the TBV, percent differences in radionuclide S values are 112%, 51%, and 200% in the ribs, lumbar vertebrae, and ox coxae, respectively for 223 Ra, and are 56%, 21%, and 93% in these same bone sites for the higher energy alpha-emitter 212 Bi. Very similar patterns and percent difference magnitudes are shown for beta-emitters and alpha-emitters localized to the bone trabeculae surfaces (e.g., 153 Sm-EDTPM and 223 RaCl).
As shown in Tables IV and V , there can exist great variations in percent differences between SðAM r S Þ and S DW ðAM r S Þ for TBV and TBS electron and alpha-particle emitters among different bones of the skeleton. This is a direct result of corresponding bone-specific variations in marrow cavity size and bone trabeculae thickness. A perhaps more informative comparison is thus between the skeletalaveraged quantities S skel ðAM r S Þ and S skel DW ðAM r S Þ as computed using Eqs. (16) and (17) . These comparisons are given in Table VI for the same beta-emitters and in Table VII for the same alpha-emitters.
For AM and IM sources, differences in volume-averaged and depth-weighted S values are once again shown to be small (less than 2%) for both particle emitters. For beta-emitters located to either the TBV or TBS, percent differences are in the range of 30-40% for the lowest energy emitter ( 45 Ca), and decrease to between À1% and +5% for the highest energy emitter ( 90 Y). Again, this is expected as the higher energy beta-particles produce a more uniform dose gradient across the marrow cavities. For alpha-particle emitters located to either the TBV or TBS, percent differences are in the range of 50-55% for the alpha-emitter 223 Ra (average energy -5.72 MeV) and fall to a range of 23-45% for the alpha-emitter 212 Bi (average energy -6.05 MeV).
As with all similar studies, there are expected limitations of the present investigation that need further consideration before systematic changes in marrow dosimetry can be proposed for either radiological protection or clinical patient dosimetry. First, the bone macrostructural and microstructural models of this study were taken from a single adult female cadaver and ICRP-defined reference values of marrow cellularity were assumed. Consequently, the impact on changes in skeletal size (e.g., patient stature), bone mineral status (e.g., osteoporosis), and marrow cellularity (e.g., disease status) were not fully considered. Second, the spatial concentration gradients of the HSPCs given in the study by Bourke et al. were measured in 2D histology tissue sections, when fully 3D spatial distributions would have been desirable. Third, a single average spatial gradient (last column of Table III ) was applied to all bone sites. In the study of Bourke et al., only three skeletal regions were considered. Still, their study demonstrated fairly consistent results across bone sites, given all other sources of subject variability.
The bone site that is perhaps the most problematic is the cranium. The majority of bones of the skeleton have trabecular bone volume fractions (TBVF) of spongiosa between 10% and 20%, while the cranial TBVF in the O'Reilly adult female model is 68%. 28 Cranial marrow cavities are thus very small and extend only to depths of between 100 and 200 lm. In the present model, the measured spatial stem cell gradients of Fig. 3 were spatially rescaled for bone sites with maximal marrow depths less than 700 lm. Resultantly, our model introduces a very steep spatial gradient in the cranium which results in depth-dependent S values that exceed volume-averaged S values, a pattern opposite to that seen in other bone sites (see Annex C). An alternative model would have been to assume no spatial gradient of HSPCs in the small marrow cavities of the cranium. Final resolution of this issue must await direct histology measurements in cranial spongiosa.
With further confirmation of the spatial gradients of the HSPCs in the adult skeleton, the modification of the MIRD schema presented here provides the framework for a more appropriate assessment of the mean absorbed dose to FIG. 9 . Depth-dependent alpha particle SAFs in the os coxae of the adult female for (a) TBV and (b) TBS sources irradiating the AM at varying depths in the marrow cavity. [Color figure can be viewed at wileyonlinelibrary.com] TABLE IV. Volume-averaged and depth-weighted radionuclide S values in the ribs, lumbar vertebrae, and os coxae of the adult female for three beta-particle emitters of increasing average particle energy (shown in parentheses). hematopoietic stem and progenitor cells. While the distinction between DðAMÞ given by Eq. (15) using the traditional volume-averaged S value and DðHCD34 þ Þ given by Eq. (14) using depth-weighted S values may be relevant to dose-response models for stochastic effects, the proposed approach might not be fully applicable to dose-response models for deterministic tissue reactions. As an example, cell survival predicted under the MIRD schema using traditional volumeaveraged S values would be expressed as:
However, this formulation does not account for the spatial gradient of the target cells. A more appropriate estimate of cell survival would utilize depth-dependent (not depthweighted) S values as given as:
TABLE V. Volume-averaged and depth-weighted radionuclide S values in the ribs, lumbar vertebrae, and os coxae of the adult female for three alpha-particle emitters of increasing average particle energy (shown in parentheses). Values of SðAM r S ; dÞ may be computed for any number of radionuclides using the depth-dependent SAFs given in Annex A and B for monoenergetic electrons and alpha particles, respectively.
CONCLUSIONS
Current models of active bone marrow dosimetry are based upon radiation dose averaged across the entire tissues of the marrow cavities, with some allowance made for the fraction of total bone marrow that is hematopoietically active (e.g., marrow cellularity). Active marrow, however, is a surrogate tissue region for the target cells of interest -the hematopoietic stem and progenitor cells. Resultantly, active marrow dose as reported by existing models implicitly assumes that the HSPCs are uniformly localized across the marrow cavities. A strong spatial gradient of the HSPCs, however, has been known for number of years in mouse femoral shaft [38] [39] [40] and more recently in human bone marrow. 7, 8 The present study thus presents a modification of the MIRD computational schema that explicitly accounts for these spatial gradients in target cell concentration.
Data from this study clearly show that when the dose gradient across the marrow cavities is nonexistent, as is the case for AM and IM sources of electrons or alpha particles, the HSPC concentration gradient is inconsequential, and differences in volume-averaged and depth-weighted radionuclide S values vary only slightly. In contrast, when a dose gradient is anticipated, as is generated by either alpha particles or lower energy beta-particles emitted within the volumes or on the surfaces of the bone trabeculae, traditional radionuclide S values of the MIRD schema will under predict radiation dose to the HPSC by up to 40-55% (see Tables VI and VII) . Over the past two decades, the internal dosimetry community has carefully revised its dosimetric models to include information on the location of radiosensitive stem cell populations in both the lung airways 41 and in walls of the alimentary tract organs. 42 The present study suggests that, for some radiation emissions and source geometries, similar considerations might be given to bone marrow dosimetry.
